DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
« Back to Dashboard
Guaifenesin; hydrocodone bitartrateis the generic ingredient in four branded drugs marketed by Bkk Pharms, Sovereign Pharms, and Eci Pharms Llc, and is included in four NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.
There are twenty drug master file entries for guaifenesin; hydrocodone bitartrate. One supplier is listed for this compound.
Recent Clinical Trials for guaifenesin; hydrocodone bitartrate
Identify potential brand extensions & 505(b)(2) entrants
|Reckitt Benckiser LLC||Phase 1|
Pharmacology for guaifenesin; hydrocodone bitartrate
|Drug Class||Opioid Agonist |
|Mechanism of Action||Opioid Agonists |
ATC Classes for guaifenesin; hydrocodone bitartrate
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.